By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Glenmark Pharmaceuticals 

B/2 & 801-805, Mahalaxmi Chambers
22, Bhulabhai Desai Road
Mumbai    400 026  India
Phone: 91-0-4964893 Fax: 91-0-4932648



Company News
Glenmark Pharma Reports Positive Data In A Phase IIa Study Of GBR 830 For The Treatment Of Patients With Atopic Dermatitis 7/31/2017 10:58:53 AM
Glenmark Pharma Enters Exclusive Agreement With Cyndea Pharma S.L. For Generic Soft-Gelatin Capsule Drug Products 7/18/2017 8:40:18 AM
Glenmark Pharma Licenses Small Molecule Oncology Compound From APC Therapeutics To Expand Immuno-Oncology Portfolio 6/20/2017 6:53:25 AM
Booming Glenmark Pharma Could File One NDA Each Year For 10 Years 6/8/2017 6:57:32 AM
Glenmark Pharma To Initiate Clinical Study For GBR 1342, Second Investigational New Drug From Immuno-Oncology Portfolio 5/15/2017 6:38:06 AM
Glenmark Pharma Initiates Clinical Investigation For GBR 310, Its Proposed Biosimilar Candidate For XOLAIR 4/25/2017 8:26:04 AM
Glenmark Pharma Reports Positive Results From A Phase III Trial Of GSP 301, Mometasone/Olopatadine Fixed-Dose Combination Nasal Spray, In Seasonal Allergic Rhinitis 3/29/2017 8:42:49 AM
Glenmark Pharma Receives FDA Clearance Of IND For GSP 304 3/7/2017 9:16:20 AM
Glenmark Pharma And Evestra Announce Partnership Agreement For Generic NuvaRing 3/2/2017 6:58:17 AM
Glenmark Pharma Receives FDA Clearance Of IND For GBR 1302-BEAT Phase I Trial 1/3/2017 6:46:20 AM